• 1-hyper-sepsis.png
  • 2-abs-system.png
  • 3-icu-640x325.jpg

Cascade Metrix (CM) is a medical technology company working within a new paradigm in critical care. The company will introduce an automated critical care blood analyzer that will revolutionize the bedside testing of hospitalized patients whose care and recovery is dependent on repetitive, around-the-clock measurements of critical blood parameters. This innovative and proprietary ex-vivo blood analysis system is first being applied to the automated measurement of glucose and lactate in critically ill patients.

CM is also actively exploring investment/partnership opportunities with firms in the medical technology and related areas. Please contact us for further details.

Aug 28, 2018: Cascade Metrix (CMX) was invited to participate in the Startup Company Showcase at the Diabetes Technology Meeting 2018!

Feb 6, 2018: Cascade Metrix [CMX] is working with the Indiana University Center for Diabetes and Metabolic Diseases to evaluate the use of automated glucose monitoring in mice studies. 

April 2, 2016: Cascade Metrix [CM] in partnership with Purdue University’s Pharmacology Testing Facility (West Lafayette, IN) conducted a 3-day pilot study on two pigs. 

Feb 10, 2016: Cascade Metrix is pleased to release preliminary results (including videos) from ongoing studies in pig and rat models.